EcoDrugPlus

Carbonic Anhydrase 3

Ensembl ID : ENSVVUG00000001617
Gene Symbol: CA3
3 Cross references
307 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSVVUG00000018348
Gene Symbol: CA4
3 Cross references
267 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSVVUG00000003089
Gene Symbol: CA5A
3 Cross references
167 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSVVUG00000026236
Gene Symbol: CA6
3 Cross references
218 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSVVUG00000011048
Gene Symbol: CA7
3 Cross references
220 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSVVUG00000024361
Gene Symbol: CA9
3 Cross references
280 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSVVUG00000022775
Gene Symbol: CSNK1E
4 Cross references
268 Possible Orthologues:

Casein Kinase 2 Alpha 1

Ensembl ID : ENSVVUG00000008179
Gene Symbol: CSNK2A1
3 Cross references
208 Possible Orthologues:

Caspase 8

Ensembl ID : ENSVVUG00000018943
Gene Symbol: CASP8
3 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSVVUG00000028939
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSVVUG00000025402
Gene Symbol: COMT
3 Cross references
275 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSVVUG00000018738
Gene Symbol: CTSC
3 Cross references
233 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).